{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:09:08Z","timestamp":1788800948971,"version":"build-2803163510"},"reference-count":68,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Atopic dermatitis (AD) is a chronic, relapsing, and remitting condition that affects approximately 10% of the population. It is a multifactorial disease involving immune dysregulation, gene mutations, and environmental factors that ultimately disrupt skin barrier restoration, causing pruritic lesions. Given the marked heterogeneity of AD and the presence of multiple immune and clinical endotypes, no single therapeutic strategy is likely to be universally effective. Instead, a growing panel of distinct biomarkers offers an avenue for true precision medicine by enabling more accurate endotype classification, prediction of treatment response, and tailored treatments. In this context, ongoing research is increasingly focused on individualized, biomarker-informed strategies, as well as the evaluation of adjunctive approaches that can be integrated with standard therapies to optimize long-term disease control. Given the central role of systemic inflammation and barrier dysfunction in AD, the mechanistic focus of osteopathic manipulative medicine (OMM) on circulation, lymphatic drainage, and autonomic regulation offers another biological treatment to use alongside conventional therapies. This concise review examines the pathogenesis of AD, current treatments and their limitations, and the expanding role of biomarkers in refining diagnosis, prognosis, and therapeutic decision-making. It also explores the potential integration of OMM as a biologically plausible adjunct to support individualized, endotype-aware treatment strategies, while emphasizing the current lack of empirical evidence and the need for rigorous mechanistic and clinical studies.<\/jats:p>","DOI":"10.3390\/ijms27177973","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:30:02Z","timestamp":1788798602000},"page":"7973","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative Approaches to Atopic Dermatitis: Exploring Biomarkers, Current Therapies, and the Potential Role of Osteopathic Manipulative Medicine"],"prefix":"10.3390","volume":"27","author":[{"given":"Stephanie","family":"Sawicki","sequence":"first","affiliation":[{"name":"Department of Microbiology & Immunology, Touro College of Osteopathic Medicine, Great Falls, MT 59404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Dhawan","sequence":"additional","affiliation":[{"name":"Department of Microbiology & Immunology, Touro College of Osteopathic Medicine, Great Falls, MT 59404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dikshya","family":"Devkota","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oklahoma Children\u2019s Hospital OU Health, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Elway","sequence":"additional","affiliation":[{"name":"Department of Primary Care & Osteopathic Medicine, Touro College of Osteopathic Medicine, Great Falls, MT 59404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish R.","family":"Maskey","sequence":"additional","affiliation":[{"name":"Department of Microbiology & Immunology, Touro College of Osteopathic Medicine, Great Falls, MT 59404, USA"},{"name":"Department of Pathology, Microbiology & Immunology, New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaad.2025.10.022","article-title":"Prevalence of atopic dermatitis in the United States from 2021 to 2024: Data from the National Health Interview Survey","volume":"94","author":"Chan","year":"2026","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.19580","article-title":"The global burden of atopic dermatitis: Lessons from the Global Burden of Disease Study 1990\u20132017","volume":"184","author":"Laughter","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_3","first-page":"12","article-title":"Phenotypes of atopic dermatitis","volume":"9","author":"Pugliarello","year":"2011","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4168\/aair.2025.17.2.165","article-title":"Skin Microbiome Dynamics in Atopic Dermatitis: Understanding Host-Microbiome Interactions","volume":"17","author":"Kim","year":"2025","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jaci.2023.08.029","article-title":"Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials","volume":"152","author":"Chu","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1091\/mbc.e07-02-0124","article-title":"LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction","volume":"18","author":"Deraison","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/75977","article-title":"Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome","volume":"25","author":"Chavanas","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng728","article-title":"Gene polymorphism in Netherton and common atopic disease","volume":"29","author":"Walley","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaci.2025.02.029","article-title":"Endotypes of Atopic Dermatitis","volume":"156","author":"Fyhrquist","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_10","unstructured":"American Academy of Pediatrics (2026, July 20). IgE Levels in Atopic Dermatitis. Available online: https:\/\/www.aap.org\/en\/patient-care\/atopic-dermatitis\/diagnosis-of-atopic-dermatitis\/ige-levels-in-atopic-dermatitis\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.2147\/JIR.S467327","article-title":"Preclinical Models of Atopic Dermatitis Suitable for Mechanistic and Therapeutic Investigations","volume":"17","author":"Maskey","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/iai.61.12.4972-4979.1993","article-title":"Staphylococcal alpha-toxin kills human keratinocytes by permeabilizing the plasma membrane for monovalent ions","volume":"61","author":"Walev","year":"1993","journal-title":"Infect. Immun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.chom.2017.10.008","article-title":"Staphylococcus aureus virulent PSM\u03b1 peptides induce keratinocyte alarmin release to orchestrate IL-17-dependent skin inflammation","volume":"22","author":"Nakagawa","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1523-1747.2003.12630.x","article-title":"Toll-like receptor expression in human keratinocytes: Nuclear factor \u03baB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent","volume":"121","author":"Mempel","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jaip.2020.02.022","article-title":"Endophenotypic variations of atopic dermatitis by age, race, and ethnicity","volume":"8","author":"Nomura","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/ACI.0b013e32832e7d36","article-title":"Abnormal skin barrier in the etiopathogenesis of atopic dermatitis","volume":"9","author":"Elias","year":"2009","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4168\/aair.2019.11.5.593","article-title":"Interactions Between Atopic Dermatitis and Staphylococcus aureus Infection: Clinical Implications","volume":"11","author":"Kim","year":"2019","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11658-025-00834-3","article-title":"The neuro-immune insights of itch: Peripheral mechanisms and central glial contributions","volume":"31","author":"Li","year":"2026","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Nemmer, J.M., Kuchner, M., Datsi, A., Ol\u00e1h, P., Julia, V., Raap, U., and Homey, B. (2021). Interleukin-31 Signaling Bridges the Gap Between Immune Cells, the Nervous System and Epithelial Tissues. Front. Med., 8.","DOI":"10.3389\/fmed.2021.639097"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100973","DOI":"10.37349\/eaa.2025.100973","article-title":"Pathogenesis and management of atopic dermatitis: Insights into epidermal barrier dysfunction and immune mechanisms","volume":"3","author":"Baidya","year":"2025","journal-title":"Explor. Asthma Allergy"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Maskey, A.R., Sasaki, A., Sargen, M., Kennedy, M., Tiwari, R.K., Geliebter, J., Safai, B., and Li, X.M. (2025). Breaking the cycle: A comprehensive exploration of topical steroid addiction and withdrawal. Front. Allergy, 6.","DOI":"10.3389\/falgy.2025.1547923"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jaci.2017.12.991","article-title":"Serum biomarker profiles suggest that atopic dermatitis is a systemic disease","volume":"141","author":"Thijs","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7697699","DOI":"10.1155\/2023\/7697699","article-title":"The Role of TSLP in Atopic Dermatitis: From Pathogenetic Molecule to Therapeutical Target","volume":"2023","author":"Luo","year":"2023","journal-title":"Mediat. Inflamm."},{"key":"ref_24","first-page":"689","article-title":"The skin\u2019s barrier","volume":"144","author":"Jensen","year":"2009","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pellefigues, C. (2020). IgE Autoreactivity in Atopic Dermatitis: Paving the Road for Autoimmune Diseases?. Antibodies, 9.","DOI":"10.3390\/antib9030047"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1046\/j.1523-1747.1998.00413.x","article-title":"Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients","volume":"111","author":"Valenta","year":"1998","journal-title":"J. Investig. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhong, L., Zhou, X., Su, J., Zhang, Y., Zhang, D., and Wan, H. (2026). Microbiome dysbiosis and therapeutic restoration in atopic dermatitis. Front. Cell. Infect. Microbiol., 16.","DOI":"10.3389\/fcimb.2026.1693905"},{"key":"ref_28","first-page":"100245","article-title":"The dual role of skin microbiome modulation in precision care for atopic dermatitis: A review","volume":"17","author":"Chen","year":"2025","journal-title":"Health Sci. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5114\/ada.2019.82821","article-title":"Staphylococcus aureus: An underestimated factor in the pathogenesis of atopic dermatitis?","volume":"36","author":"Blicharz","year":"2019","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e166821","DOI":"10.1172\/jci.insight.166821","article-title":"Staphylococcus aureus exacerbates dermal IL-33\/ILC2 axis activation through evoking RIPK3\/MLKL-mediated necroptosis of dry skin","volume":"9","author":"Luo","year":"2024","journal-title":"JCI Insight"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1016\/j.cell.2023.10.019","article-title":"S. aureus drives itch and scratch-induced skin damage through a V8 protease\u2013PAR1 axis","volume":"186","author":"Deng","year":"2023","journal-title":"Cell"},{"key":"ref_32","first-page":"e77981","article-title":"An Update on the Role of Lymphatic Function in Skin Inflammatory Disorders: A Scoping Review","volume":"17","author":"Tashjian","year":"2025","journal-title":"Cureus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1038\/jid.2015.283","article-title":"Lymphatic Function Regulates Contact Hypersensitivity Dermatitis in Obesity","volume":"135","author":"Savetsky","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"18079","DOI":"10.2147\/JIR.S578036","article-title":"The Neuroimmune Axis in Atopic Dermatitis: From Pathogenic Mechanisms to Targeted Neuroimmunotherapy","volume":"18","author":"Zhang","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jaci.2021.09.014","article-title":"IL-33 signaling in sensory neurons promotes dry skin itch","volume":"149","author":"Trier","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.jaci.2003.09.032","article-title":"Immune mechanisms leading to atopic dermatitis","volume":"112","author":"Novak","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaci.2023.01.019","article-title":"Biomarkers in atopic dermatitis","volume":"151","author":"Bakker","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaci.2021.01.013","article-title":"Biomarkers in atopic dermatitis\u2014A review on behalf of the International Eczema Council","volume":"147","author":"Thyssen","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40257-024-00913-9","article-title":"Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment","volume":"26","author":"Gorelick","year":"2025","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"105121","DOI":"10.1016\/j.ebiom.2024.105121","article-title":"Biomarkers for phenotype-endotype relationship in atopic dermatitis: A critical review","volume":"103","author":"Park","year":"2024","journal-title":"EBioMedicine"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Sargen, M., Sasaki, A., Maskey, A.R., and Li, X.M. (2025). Biomarkers to aid in diagnosis of allergic contact dermatitis. Front. Allergy, 6.","DOI":"10.3389\/falgy.2025.1564588"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cod.14391","article-title":"Epidermal biomarkers of the skin barrier in atopic and contact dermatitis","volume":"89","author":"Kezic","year":"2023","journal-title":"Contact Dermat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jama.2025.11589","article-title":"Treatment of Atopic Dermatitis","volume":"334","author":"Drucker","year":"2025","journal-title":"JAMA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaci.2014.05.048","article-title":"Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis","volume":"134","author":"Elias","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_45","first-page":"e56890","article-title":"A Comprehensive Review of Phototherapy in Atopic Dermatitis: Mechanisms, Modalities, and Clinical Efficacy","volume":"16","author":"Molla","year":"2024","journal-title":"Cureus"},{"key":"ref_46","unstructured":"Gabros, S., Nessel, T.A., and Zito, P.M. (2025). Topical Corticosteroids. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5114\/pdia.2014.40962","article-title":"Topical steroid therapy in atopic dermatitis in theory and practice","volume":"32","author":"Jeziorkowska","year":"2015","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2014.11.024","article-title":"A systematic review of topical corticosteroid withdrawal (\u201csteroid addiction\u201d) in patients with atopic dermatitis and other dermatoses","volume":"72","author":"Hajar","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/bjd\/ljaf518","article-title":"Topical steroid withdrawal syndrome: Developing diagnostic criteria through a modified Delphi method","volume":"194","author":"Hsu","year":"2026","journal-title":"Br. J. Dermatol."},{"key":"ref_50","first-page":"e268","article-title":"The long-term safety of topical corticosteroids in atopic dermatitis: A systematic review","volume":"3","author":"Harvey","year":"2023","journal-title":"Ski. Health Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.46747\/cfp.6911773","article-title":"Topical calcineurin inhibitors for atopic dermatitis","volume":"69","author":"Braschi","year":"2023","journal-title":"Can. Fam. Physician"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jdermsci.2025.04.001","article-title":"Stratum corneum pH and ceramides: Key regulators and biomarkers of skin barrier function in atopic dermatitis","volume":"118","author":"Sakai","year":"2025","journal-title":"J. Dermatol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Pappa, G., Sgouros, D., Theodoropoulos, K., Kanelleas, A., Bozi, E., Gregoriou, S., Krasagakis, K., and Katoulis, A.C. (2022). The IL-4\/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11195633"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjd.19574","article-title":"Tralokinumab for moderate-to-severe atopic dermatitis: Results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)","volume":"184","author":"Wollenberg","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(24)01203-0","article-title":"Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): Results from two replicate, double-blind, randomised controlled phase 3 trials","volume":"404","author":"Silverberg","year":"2024","journal-title":"Lancet"},{"key":"ref_56","unstructured":"Padda, I.S., Bhatt, R., Patel, P., and Parmar, M. (2024). Upadacitinib. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_57","unstructured":"Haq, M., and Adnan, G. (2023). Ruxolitinib. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2133.2008.08756.x","article-title":"Does autonomic dysfunction play a role in atopic dermatitis?","volume":"159","author":"Cicek","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/lrb.2008.1008","article-title":"The lymphatic system in health and disease","volume":"6","author":"Cueni","year":"2008","journal-title":"Lymphat. Res. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/lrb.2012.0021","article-title":"Lymphatic pump treatment repeatedly enhances the lymphatic and immune systems","volume":"11","author":"Schander","year":"2013","journal-title":"Lymphat. Res. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1258\/ebm.2011.011057","article-title":"Lymphatic pump treatment enhances the lymphatic and immune systems","volume":"236","author":"Hodge","year":"2011","journal-title":"Exp. Biol. Med."},{"key":"ref_62","first-page":"e16448","article-title":"The Lymphatic System: An Osteopathic Review","volume":"13","author":"Hruby","year":"2021","journal-title":"Cureus"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-4732-2-7","article-title":"Osteopathic manipulative treatment and its relationship to autonomic nervous system activity as demonstrated by heart rate variability: A repeated measures study","volume":"2","author":"Henley","year":"2008","journal-title":"Osteopath. Med. Prim. Care"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Ruffini, N., D\u2019Alessandro, G., Mariani, N., Pollastrelli, A., Cardinali, L., and Cerritelli, F. (2015). Variations of high frequency parameter of heart rate variability following osteopathic manipulative treatment in healthy subjects compared to control group and sham therapy: Randomized controlled trial. Front. Neurosci., 9.","DOI":"10.3389\/fnins.2015.00272"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Feldman, S.R., Strowd, L.C., and Lovell, K.K. (2024). The Economic Impact of Atopic Dermatitis. Management of Atopic Dermatitis, Springer.","DOI":"10.1007\/978-3-031-54513-9"},{"key":"ref_66","first-page":"e52665","article-title":"Integrating Osteopathic Principles for Enhanced Dermatological Outcomes: A Literature Review","volume":"16","author":"Ventura","year":"2024","journal-title":"Cureus"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s43556-025-00313-3","article-title":"Atopic dermatitis: Diagnosis, molecular pathogenesis, and therapeutics","volume":"6","author":"Bai","year":"2025","journal-title":"Mol. Biomed."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Roberts, A., Harris, K., Outen, B., Bukvic, A., Smith, B., Schultz, A., Bergman, S., and Mondal, D. (2022). Osteopathic Manipulative Medicine: A Brief Review of the Hands-On Treatment Approaches and Their Therapeutic Uses. Medicines, 9.","DOI":"10.3390\/medicines9050033"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7973\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:31:07Z","timestamp":1788798667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":68,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177973"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177973","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}